Filter your results
- 25
- 8
- 22
- 10
- 1
- 33
- 2
- 1
- 3
- 1
- 3
- 2
- 3
- 4
- 4
- 1
- 5
- 1
- 1
- 1
- 1
- 21
- 12
- 29
- 5
- 1
- 1
- 1
- 33
- 3
- 3
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Pharmaceutical firms and the construction of drug markets: from branding to scientific marketing. IntroductionHistory and Technology, 2013, 29 (2), pp.105-115. ⟨10.1080/07341512.2013.828867⟩
Journal articles
hal-03478904v1
|
||
Du risque social au risque technologique : la transformation de la tuberculose en problème globalD. Bourg; P. B. Joly; A. Kaufman. La société du risque revisitée, Actes du Colloque de Cerisy, PUF, pp.313-338, 2013
Book sections
hal-03707684v1
|
|||
Jacques Monod, la politique des sciences et l’institutionalisation de la biologie moléculaireL. Loison; M. Morange. L’invention de la regulation génétique. Les Nobel 1965 (Jacob, Lwoff, Monod) et le modèle de l’opéron dans l’histoire de la biologie, Editions ENS Rue d’Ulm, pp.167-182, 2016
Book sections
hal-03707568v1
|
|||
Ads, Ads, Ads: The Gephama Database and its UsesJ.-P. Gaudillière; U. Thoms. The Development of Scientific Marketing in the Twentieth Century, Pickering & Chatto, pp.63-85, 2015
Book sections
hal-03707729v1
|
|||
BiomédecineD. Fassin; B. Hauray. Santé publique: l'état des savoirs, La Découverte, pp.23-33, 2010, 9782707164902
Book sections
hal-03707565v1
|
|||
Marketing Loops: Clinical Research, Consumption of Antidepressants and the Reorganization of Promotion at Geigy in the 1960s and 1970sJ.-P. Gaudillière; U. Thoms. The Development of Scientific Marketing in the Twentieth Century, Pickering & Chatto, pp.167-189, 2015
Book sections
hal-03707690v1
|
|||
|
The local roots of ‘health for all’: Primary health care in practices, 1950s–2000sSocial science & medicine, 2022, pp.115321. ⟨10.1016/j.socscimed.2022.115321⟩
Journal articles
halshs-03793649v1
|
||
The Hereditary Transmission of Human Pathologies between 1900 and 1940: The Good Reasons Not to Become “Mendelian”S. Müller-Wille; C. Brandt. Heredity Explored, Between Public Domain and Experimental Science, 1850–1930, MIT Press, pp.311-335, 2016
Book sections
hal-03707499v1
|
|||
IntroductionJ.-P. Gaudillière; U. Thoms. The Development of Scientific Marketing in the Twentieth Century, Pickering & Chatto, pp.1-14, 2015
Book sections
hal-03707536v1
|
|||
Essais cliniques et médecine des preuves, Médecine, marchés et santé publiqueC. Bonah. Médecine, santé et sciences humaines, Les Belles Lettres, pp.577-582, 2011, 9782251430263
Book sections
hal-03707853v1
|
|||
|
Une marchandise scientifique ? Savoirs, industrie et régulation du médicament dans l'Allemagne des années trenteAnnales. Histoire, Sciences sociales, 2010, 65 (1), pp.89-120
Journal articles
halshs-00683128v1
|
||
Scarcity, Tinkering, and Covid-19 Testing Policy in FranceInternational Exploratory Webinar ‘Testing, contact tracing and isolation policies in Covid-19: national experiences and international norms’, Jan 2021, Paris (en ligne), France
Conference papers
halshs-03963898v1
|
|||
Biologicals in the colonies : Emile Perrot, kola nuts and the industrial reordering of pharmacyH. Stoff; A. Schwering; B. Wahrig. Trajectories and standardization of biological drugs, Pickering & Chatto, 2013
Book sections
hal-03707634v1
|
|||
DES, cancer and endocrine disruptors. Ways of regulating, chemical risks and public expertise in the United StatesN. Jas; B. Soraya. Powerless Science. Science and Politics in a Toxic World, Berghahn Books, pp.65-94, 2014, 978-1-78238-236-2
Book sections
hal-03707526v1
|
|||
|
Covid-19 and global health, seen from France: the end of a “great divide”?Somatosphere: Science, Medicine, Anthropology, 2020
Journal articles
halshs-03035506v1
|
||
How pharmaceuticals became patentable: the production and appropriation of drugs in the twentieth centuryHistory and Technology, 2008, 24 (2), pp.99-106. ⟨10.1080/07341510701810906⟩
Journal articles
hal-03477094v1
|
|||
L’industrialisation du médicament: une histoire de pratiques entre sciences, techniques, droit et médecineGesnerus, 2007, 64, pp.93-108
Journal articles
hal-03476948v1
|
|||
|
Introduction: Industrial AyurvedaAsian Medicine, 2014, 9 (1-2), pp.1-11. ⟨10.1163/15734218-12341325⟩
Journal articles
hal-03478885v1
|
||
|
Herbalised Ayurveda?Asian Medicine, 2014, 9 (1-2), pp.171-205. ⟨10.1163/15734218-12341294⟩
Journal articles
hal-03478931v1
|
||
|
Provincializing the WHOGlobal Health for All: Knowledge, Politics, Practices, Rutgers University Press, 2022
Book sections
hal-03894527v1
|
||
From imperial divergence to global convergence. Medicinal plants between east and westS. Forbes. A cultural history of plants, Bloomsbury Academic Publishing, 2017
Book sections
hal-03707691v1
|
|||
Food, drug and consumer regulation : the 'meat, DES and cancer' debates in the United StatesD. Cantor; C. Bonah; M. Dörries. Meat, Medicine and Human Health in the Twentieth Century, Pickering & Chatto, pp.179-202, 2010, 9781848931039
Book sections
hal-03707713v1
|
|||
Le tournant moléculaire de la santé mentale. A propos des psychotropes, de leur historiographie et de l’innovation pharmaceutiqueI. Coutant; S. Wang. Santé mentale et souffrance psychique. Un objet pour les sciences sociales, 2017
Book sections
hal-03707612v1
|
|||
Professional and industrial régulation in France and Germany : The trajectory of plant extractsJ.-P. Gaudillière; V. Hess. Ways of Regulating Drugs in the 19th and 20th centuries, Palgrave Macmillan, pp.66-96, 2013
Book sections
hal-03707676v1
|
|||
New wine in old bottles? The biotechnology problem in the history of molecular biologyStudies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences, 2009, 40 (1), pp.20-28. ⟨10.1016/j.shpsc.2008.12.004⟩
Journal articles
hal-03477254v1
|
|||
Génomique à haut débit et innovations thérapeutiques en cancérologie. Regards croisés sur les enjeux épistémiques et sociauxN. Anselme; P. Bataille. Le cancer : un regard sociologique. Biomédicalisation et parcours de soins, Presses Universitaires de Rennes, 2018
Book sections
hal-03707552v1
|
|||
A Comparative and Social History of Genetic Counselling?H. I. Petermann; P. S. Harper; S. Doetz. History of human genetics, Springer International Publishing, pp.567-576, 2017, 978-3-319-51783-4. ⟨10.1007/978-3-319-51783-4_32⟩
Book sections
hal-03707850v1
|
|||
Une nouvelle économie de la promesse : cancer, risque et biotechnologieA. Leibing; V. Tournay. Les technologies de l'espoir - la fabrique d'une histoire à accomplir, Presses de l'Université de Laval, pp.221-240, 2010, 9782763789958
Book sections
hal-03707616v1
|
|||
The visible industrialist : standards and the manufacture of sex hormonesC. Gradmann; J. Simon. Evaluating and standardizing therapeutic agents, Palgrave-Macmillan, pp.174-201, 2010, 9780230202818
Book sections
hal-03707730v1
|
|||
|
Hérédité, statistique et santé publique : Notes sur la comparaison France-AngleterreLa Lettre de la Maison Française d'Oxford, 1997, 7, pp.166-176
Journal articles
hal-02560379v1
|
- 1
- 2